Cargando…
A clinical comparison of etomidate-lipuro, propofol and admixture at induction
OBJECTIVE: The purpose of this study was to compare etomidate-lipuro and propofol and 50%, (1:1) admixture of these agents at induction with special reference to injection pain, hemodynamic changes, and myoclonus. METHODS: Ninety patients were assigned at random to three groups in which induction wa...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101756/ https://www.ncbi.nlm.nih.gov/pubmed/21655019 http://dx.doi.org/10.4103/1658-354X.76509 |
_version_ | 1782204302199095296 |
---|---|
author | Saricaoglu, Fatma Uzun, Sennur Arun, Oguzhan Arun, Funda Aypar, Ulku |
author_facet | Saricaoglu, Fatma Uzun, Sennur Arun, Oguzhan Arun, Funda Aypar, Ulku |
author_sort | Saricaoglu, Fatma |
collection | PubMed |
description | OBJECTIVE: The purpose of this study was to compare etomidate-lipuro and propofol and 50%, (1:1) admixture of these agents at induction with special reference to injection pain, hemodynamic changes, and myoclonus. METHODS: Ninety patients were assigned at random to three groups in which induction was performed with either etomidate-lipuro, propofol or etomidate-lipuro–propofol admixture. After monitorization with bispectral index (BIS) all agents were given with infusion with a perfuser at a constant rate of 200 ml/min till the BIS values decreased to 40. Blood pressure and heart rate were measured every 30 s at this period. Patients were asked for pain at the injection site and observed visually for myoclonus. The time BIS values decreased to 40 (BIS 40 time) and total amounts of induction doses were measured. RESULTS: BIS 40 time measurements were P > E > PE (199.4 ± 40.9, 176.9 ± 31.6, 163.5 ± 20.6 s). The hemodynamic (systolic, diastolic and mean blood pressures, heart rate) changes were minimal in group PE than other two groups (P = 0.017). The intensity of myoclonus was graded as mild in 9, moderate in 12, and severe in 5 patients in the group E (76.3%). Myoclonus was not observed in group PE and group P. There were no injection pain in group PE as the incidence were (83.8%) in group P and in (63.2%) group E. CONCLUSION: Incidence of hemodynamic changes, myoclonus, and injection pain is significantly lower in group PE. BIS 40 times is least in group PE. We concluded that 1:1 admixture of etomidate-lipuro and propofol is a valuable agent for induction. |
format | Text |
id | pubmed-3101756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-31017562011-06-08 A clinical comparison of etomidate-lipuro, propofol and admixture at induction Saricaoglu, Fatma Uzun, Sennur Arun, Oguzhan Arun, Funda Aypar, Ulku Saudi J Anaesth Original Article OBJECTIVE: The purpose of this study was to compare etomidate-lipuro and propofol and 50%, (1:1) admixture of these agents at induction with special reference to injection pain, hemodynamic changes, and myoclonus. METHODS: Ninety patients were assigned at random to three groups in which induction was performed with either etomidate-lipuro, propofol or etomidate-lipuro–propofol admixture. After monitorization with bispectral index (BIS) all agents were given with infusion with a perfuser at a constant rate of 200 ml/min till the BIS values decreased to 40. Blood pressure and heart rate were measured every 30 s at this period. Patients were asked for pain at the injection site and observed visually for myoclonus. The time BIS values decreased to 40 (BIS 40 time) and total amounts of induction doses were measured. RESULTS: BIS 40 time measurements were P > E > PE (199.4 ± 40.9, 176.9 ± 31.6, 163.5 ± 20.6 s). The hemodynamic (systolic, diastolic and mean blood pressures, heart rate) changes were minimal in group PE than other two groups (P = 0.017). The intensity of myoclonus was graded as mild in 9, moderate in 12, and severe in 5 patients in the group E (76.3%). Myoclonus was not observed in group PE and group P. There were no injection pain in group PE as the incidence were (83.8%) in group P and in (63.2%) group E. CONCLUSION: Incidence of hemodynamic changes, myoclonus, and injection pain is significantly lower in group PE. BIS 40 times is least in group PE. We concluded that 1:1 admixture of etomidate-lipuro and propofol is a valuable agent for induction. Medknow Publications 2011 /pmc/articles/PMC3101756/ /pubmed/21655019 http://dx.doi.org/10.4103/1658-354X.76509 Text en © Saudi Journal of Anaesthesia http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Saricaoglu, Fatma Uzun, Sennur Arun, Oguzhan Arun, Funda Aypar, Ulku A clinical comparison of etomidate-lipuro, propofol and admixture at induction |
title | A clinical comparison of etomidate-lipuro, propofol and admixture at induction |
title_full | A clinical comparison of etomidate-lipuro, propofol and admixture at induction |
title_fullStr | A clinical comparison of etomidate-lipuro, propofol and admixture at induction |
title_full_unstemmed | A clinical comparison of etomidate-lipuro, propofol and admixture at induction |
title_short | A clinical comparison of etomidate-lipuro, propofol and admixture at induction |
title_sort | clinical comparison of etomidate-lipuro, propofol and admixture at induction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101756/ https://www.ncbi.nlm.nih.gov/pubmed/21655019 http://dx.doi.org/10.4103/1658-354X.76509 |
work_keys_str_mv | AT saricaoglufatma aclinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction AT uzunsennur aclinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction AT arunoguzhan aclinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction AT arunfunda aclinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction AT ayparulku aclinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction AT saricaoglufatma clinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction AT uzunsennur clinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction AT arunoguzhan clinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction AT arunfunda clinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction AT ayparulku clinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction |